Richmond, CA, United States of America

Angela R Brooks-Wiison


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Angela R. Brooks-Wilson**

Introduction

Angela R. Brooks-Wilson is a distinguished inventor based in Richmond, CA, known for her significant contributions to the field of cholesterol regulation. With a focus on innovative methods and reagents, Brooks-Wilson has made notable strides in the diagnosis and treatment of abnormal cholesterol levels. Her work is pivotal in advancing our understanding of cholesterol modulation and its implications for health.

Latest Patents

Brooks-Wilson holds two patents that highlight her groundbreaking research. The first patent, titled "Methods and reagents for modulating cholesterol levels," features ABC1 nucleic acids and polypeptides aimed at diagnosing and treating abnormal cholesterol regulation. This invention also outlines methods for identifying compounds that can effectively modulate cholesterol levels in animals, including humans. The second patent, "Process for identifying modulators of ABC1 activity," mirrors the focus of her first patent, emphasizing the importance of ABC1 nucleic acids and polypeptides in addressing cholesterol regulation issues and further presenting methods for discovering modulators of ABC1 activity.

Career Highlights

Throughout her career, Brooks-Wilson has made significant contributions while working with several prominent companies. She has been associated with Xenon Genetics Inc. and Xenon Pharmaceuticals Inc., where she applied her expertise to research and development projects that push the boundaries of genetic and pharmaceutical innovations.

Collaborations

Angela has collaborated with notable colleagues in her field, including Michael R. Hayden and Simon N. Pimstone. These collaborations have undoubtedly enriched her work and expanded the reach of her research contributions.

Conclusion

Angela R. Brooks-Wilson's contributions to the field of cholesterol modulation are commendable, and her patents represent key advancements in medical science. Through her work, she continues to inspire future innovations that may positively impact health outcomes related to cholesterol regulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…